Informações:
Falhas:
ID
42292
Descrição
Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for immunosuppressive premedication. If a text field can't be filled out, note 'ND'.
Link
Palavras-chave
Versões (2)
- 30/10/2020 30/10/2020 -
- 07/05/2021 07/05/2021 -
Titular dos direitos
LEOSS
Transferido a
7 de maio de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients
Immunosuppressive premedication
- StudyEvent: ODM
Similar models
Immunosuppressive premedication
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item
Obinutuzumab in the last 6 months
integer
C2742503 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ocrelizumab in the last 6 months
integer
C1882138 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Ofatumumab in the last 3 months
integer
C1832027 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Rituximab in the last 6 months
integer
C0393022 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Alemtuzumab in the last 12 months
integer
C0383429 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Anti-CD79b
C0104979 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
C0003241 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: B Lymphocyte stimulator-specific inhibitor (BLyS)
C0003241 (UMLS CUI-1)
C3160093 (UMLS CUI-2)
C3160093 (UMLS CUI-2)
Item
Belimumab in the last 6 months
integer
C1723401 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Complement inhibitors
C0003241 (UMLS CUI-1)
C1564892 (UMLS CUI-2)
C1564892 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Integrin antagonists
C0003241 (UMLS CUI-1)
C2917367 (UMLS CUI-2)
C2917367 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: Interleukin inhibitors
C3653320 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
C0003241 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Antibodies: TNF-alpha inhibitors
C3653350 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
C0003241 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other Antibodies
Item
Indicate other Antibodies
text
C0205394 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,3])
Item Group
Inhibitors: Co-stimulation inhibitors
C0003241 (UMLS CUI-1)
C1622572 (UMLS CUI-2)
C1999216 (UMLS CUI-3)
C1622572 (UMLS CUI-2)
C1999216 (UMLS CUI-3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: Calcineurin inhibitors
C1562036 (UMLS CUI-1)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Inhibitors: Interleukin inhibitor
C3653320 (UMLS CUI-1)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other inhibitors
Item
Indicate other inhibitors
text
C0205394 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
C0243077 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,2])
C0243077 (UMLS CUI [1,3])
Item Group
Checkpoint inhibitors: last 3 months
C0332185 (UMLS CUI-1)
C4733472 (UMLS CUI-2)
C4733472 (UMLS CUI-2)
Recent: Nivolumab
Item
Nivolumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C3657270 (UMLS CUI [1,2])
C3657270 (UMLS CUI [1,2])
Recent: Pembrolizumab
Item
Pembrolizumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C3658706 (UMLS CUI [1,2])
C3658706 (UMLS CUI [1,2])
Recent: Ipilimumab
Item
Ipilimumab in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C1367202 (UMLS CUI [1,2])
C1367202 (UMLS CUI [1,2])
Recent: Other checkpoint inhibitor
Item
Other checkpoint inhibitor in the last 3 months
boolean
C0332185 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Indicate recent other checkpoint inhibitor
Item
Indicate other checkpoint inhibitor in the last 3 months
text
C0332185 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
No recent checkpoint inhibitor therapy
Item
No checkpoint inhibitor therapy in the last 3 months
boolean
C1298908 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Unknown Checkpoint inhibitor therapy
Item
Unknown
boolean
C0439673 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,2])
C4733472 (UMLS CUI [1,3])
Item Group
Chemotherapeutics: Antimetabolites
C0003376 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
C0729502 (UMLS CUI-2)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Mycophenolate mofetil / Mycophenolic acid
integer
C0209368 (UMLS CUI [1])
C0026933 (UMLS CUI [2])
C0026933 (UMLS CUI [2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Chemotherapeutics: Cytostatics
C0010858 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
C0729502 (UMLS CUI-2)
Item
Cladribine (2-CDA) i.v./s.c. in the last 12 months
integer
C0092801 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0092801 (UMLS CUI [2,1])
C0021499 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0092801 (UMLS CUI [2,1])
C0021499 (UMLS CUI [2,2])
C0332185 (UMLS CUI [2,3])
Code List
Cladribine (2-CDA) i.v./s.c. in the last 12 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cladribine (2-CDA) p.o. in the last 12 months
integer
C0092801 (UMLS CUI [1,1])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Code List
Cladribine (2-CDA) p.o. in the last 12 months
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cyclophosphamide i.v. in the last 3 months
integer
C0010583 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0348016 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cyclophosphamide p.o. in the last 3 months
integer
C0010583 (UMLS CUI [1,1])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0001563 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Mitoxantrone in the last 3 months
integer
C0026259 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other Chemotherapeutics
C0205394 (UMLS CUI-1)
C0729502 (UMLS CUI-2)
C0729502 (UMLS CUI-2)
Item
Other Chemotherapeutics
integer
C0205394 (UMLS CUI [1,1])
C0729502 (UMLS CUI [1,2])
C0729502 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other Chemotherapeutics
Item
Indicate other Chemotherapeutics
text
C0729502 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item Group
Other immunosuppressive regimens: Corticosteroids
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0001617 (UMLS CUI-3)
C0205394 (UMLS CUI-2)
C0001617 (UMLS CUI-3)
Item
< 10 mg / d prednisolone equivalent
integer
C0445550 (UMLS CUI [1,1])
C0038317 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
10 - 100 mg / d prednisolone equivalent
integer
C0439536 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,3])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
> 100 mg / d prednisolone equivalent
integer
C0038317 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Fumarate
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0220833 (UMLS CUI-3)
C0205394 (UMLS CUI-2)
C0220833 (UMLS CUI-3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Dimethyl fumarate / ethyl hydrogen fumarate
integer
C0058218 (UMLS CUI [1,1])
C0059764 (UMLS CUI [1,2])
C0633802 (UMLS CUI [2])
C0059764 (UMLS CUI [1,2])
C0633802 (UMLS CUI [2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Immunoglobulines
C1963758 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0021081 (UMLS CUI-3)
C0205394 (UMLS CUI-2)
C0021081 (UMLS CUI-3)
Item
Immunoglobulins i.v.
integer
C0021027 (UMLS CUI [1,1])
C0348016 (UMLS CUI [1,2])
C0348016 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Immunoglobulins s.c.
integer
C0021027 (UMLS CUI [1,1])
C0021499 (UMLS CUI [1,2])
C0021499 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Interferon
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C3652465 (UMLS CUI-3)
C0205394 (UMLS CUI-2)
C3652465 (UMLS CUI-3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens: Other Multiple Sclerosis drugs
C0021081 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0026769 (UMLS CUI-4)
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0026769 (UMLS CUI-4)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Other immunosuppressive regimens
C0205394 (UMLS CUI-1)
C0021081 (UMLS CUI-2)
C0021081 (UMLS CUI-2)
Item
Other immunosuppressive drugs
integer
C0021081 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Indicate other immunosuppressive drugs
Item
Indicate other immunosuppressive drugs
text
C0021081 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item Group
Immunosuppressive drugs: Underlying disease
C0021081 (UMLS CUI-1)
C3146298 (UMLS CUI-2)
C3146298 (UMLS CUI-2)
Indication for immunosuppressive drugs: Multiple Sclerosis
Item
Multiple Sclerosis
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Other neurological autoimmune diseases
Item
Other neurological autoimmune diseases
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0205494 (UMLS CUI [1,3])
C0004364 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
C3146298 (UMLS CUI [1,2])
C0205494 (UMLS CUI [1,3])
C0004364 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
Indication for immunosuppressive drugs: Oncology
Item
Oncology
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0205478 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C0205478 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Organ transplantation
Item
Organ transplantation
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0029216 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C0029216 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Rheumatic diseases
Item
Rheumatic diseases
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C3495832 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C3495832 (UMLS CUI [1,3])
Indication for immunosuppressive drugs: Other Underlying disease
Item
Other Underlying disease
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Indication for immunosuppressive drugs: Indicate other Underlying disease
Item
Indicate other Underlying disease
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521902 (UMLS CUI [1,5])
C3146298 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521902 (UMLS CUI [1,5])
Indication for immunosuppressive drugs: Unknown underlying disease
Item
Unknown
boolean
C0021081 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0277554 (UMLS CUI [1,4])
C3146298 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0277554 (UMLS CUI [1,4])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Is data entry for this section finished?
Item
Is data entry for this section finished?
boolean
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Sem comentários